Publikationen 2004
Prevalence of nosocomial infections in Swiss children"s hospitals
Muhlemann K, Franzini C, Aebi C, Berger C, Nadal D, Stahelin J, Gnehm H, Posfay-Barbe K, Gervaix A, Sax H, Heininger U, Bonhoeffer J, Eich G, Kind C, Petignat C, Scalfaro P
Infect Control Hosp Epidemiol. 2004 Sep;25(9):765-71
Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection
Azzola A, Passweg JR, Habicht JM, Bubendorf L, Tamm M, Gratwohl A, Eich G
J Clin Microbiol. 2004 Oct;42(10):4805-8
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Trkola A, Kuster H, Leemann C, Oxenius A, Fagard C, Furrer H, Battegay M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Bonhoeffer S, Gunthard HF; Swiss HIV Cohort Study
Blood. 2004 Sep 15;104(6):1784-92
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: Prospective multicentre study
Zellweger C, Opravila M, Bernasconib E, Cavassini M, Bucher HC, Schiffer V, Wagels T, Flepp M, Rickenbach M, Furrer H; Swiss HIV Cohort Study
AIDS 2004 Oct 21;18(15):2047-2053
Antiretroviral Treatment and Osteonecrosis in Patients of the Swiss HIV Cohort Study: A Nested Case-Control Study
Hasse B, Ledergerber B, Egger M, Flepp M, Bachmann S, Bernasconi E, Egger M, Guyot S, Hirschel B, Weber R, Günthard HF; Swiss HIV Cohort Study
ARHR 2004; 20(9):909-915
[abstract] [full-text/pdf]
Is unsafe sexual behaviour increasing among HIV-infected individuals?
Glass TR, Young J, Vernazza PL, Rickenbach M, Weber R, Cavassini M, Hirschel B, Battegay M, Bucher HC; Swiss HIV Cohort Study
AIDS 2004 Aug 20;18(12):1707-14
Infrequent transmission of HIV-1 drug-resistant variants
Yerly S, Jost S, Telenti A, Flepp M, Kaiser L, Chave JP, Vernazza P, Battegay M, Furrer H, Chanzy B, Burgisser P, Rickenbach M, Gebhardt M, Bernard MC, Perneger T, Hirschel B, Perrin L; Swiss HIV Cohort Study
Antivir Ther. 2004 Jun;9(3):375-84
[abstract] [full-text/pdf]
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann GR, Khanna N, Weber R, Perrin L, Furrer H, Cavassini M, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study.
Antivir Ther. 2004;9(2):263-74
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS; Quest Study and the Duke-UNC-Emory Acute HIV Consortium.
JID 2004;189:1785-1791
Sexual Risk Behavior in HIV-Infected Injection Drug Users
Battegay M, Bucher HC, Vernazza P.
CID 2004;38:1175-1176
Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection
Kahlert C, Hupfer M, Wagels T, Bueche D, Fierz W, Walker U A., and Vernazza P
AIDS 2004;18(6):955-957
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
Young J, De Geest S, Spirig R, Flepp M, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Telenti A, Vernazza P, Battegay M, Bucher HC; Swiss HIV Cohort Study Group.
BMJ 2004;328:15-0
Gynecomastia and potent antiretroviral therapy
Strub,C.; Kaufmann,G.R.; Flepp,M.; Egger,M.; Kahlert,C.; Cavassini,M.; Battegay,M.
AIDS 2004 vol 18 No 9; 1347-1349
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
Opravil,M.; Baumann,D.; Chave,J.P.; Furrer,H.; Calmy,A.; Bernasconi,E.; Blasko,M.; Vernazza,P.; Ledergerber,B.; Perrin,L.
AIDS Nov 2004; Vol. 18, Issue 16: 2213-2215
